1. Home
  2. PETS vs ANIX Comparison

PETS vs ANIX Comparison

Compare PETS & ANIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PETS
  • ANIX
  • Stock Information
  • Founded
  • PETS 1996
  • ANIX 1982
  • Country
  • PETS United States
  • ANIX United States
  • Employees
  • PETS N/A
  • ANIX N/A
  • Industry
  • PETS Retail-Drug Stores and Proprietary Stores
  • ANIX Biotechnology: Pharmaceutical Preparations
  • Sector
  • PETS Consumer Staples
  • ANIX Health Care
  • Exchange
  • PETS Nasdaq
  • ANIX Nasdaq
  • Market Cap
  • PETS 87.1M
  • ANIX 87.1M
  • IPO Year
  • PETS N/A
  • ANIX 1987
  • Fundamental
  • Price
  • PETS $3.92
  • ANIX $2.77
  • Analyst Decision
  • PETS Buy
  • ANIX Strong Buy
  • Analyst Count
  • PETS 2
  • ANIX 1
  • Target Price
  • PETS $5.25
  • ANIX $7.00
  • AVG Volume (30 Days)
  • PETS 542.7K
  • ANIX 57.9K
  • Earning Date
  • PETS 07-29-2024
  • ANIX 09-04-2024
  • Dividend Yield
  • PETS 7.65%
  • ANIX N/A
  • EPS Growth
  • PETS N/A
  • ANIX N/A
  • EPS
  • PETS N/A
  • ANIX N/A
  • Revenue
  • PETS $281,064,000.00
  • ANIX N/A
  • Revenue This Year
  • PETS $2.07
  • ANIX N/A
  • Revenue Next Year
  • PETS $4.31
  • ANIX N/A
  • P/E Ratio
  • PETS N/A
  • ANIX N/A
  • Revenue Growth
  • PETS 9.54
  • ANIX N/A
  • 52 Week Low
  • PETS $3.63
  • ANIX $2.15
  • 52 Week High
  • PETS $15.08
  • ANIX $5.13
  • Technical
  • Relative Strength Index (RSI)
  • PETS 44.89
  • ANIX 63.52
  • Support Level
  • PETS $3.63
  • ANIX $2.16
  • Resistance Level
  • PETS $4.49
  • ANIX $2.61
  • Average True Range (ATR)
  • PETS 0.20
  • ANIX 0.14
  • MACD
  • PETS -0.03
  • ANIX 0.05
  • Stochastic Oscillator
  • PETS 33.72
  • ANIX 91.18

About PETS PetMed Express Inc.

PetMed Express Inc along with its subsidiaries is a nationwide pet pharmacy. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The company generates its revenue by selling pet medications and pet supplies primarily to retail consumers.

About ANIX Anixa Biosciences Inc.

Anixa Biosciences Inc, a cancer-focused biotechnology company, developing vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.

Share on Social Networks: